/Companies

Fimmcyte

Basel, CH · 1 known investors

Find your way into Fimmcyte

Sign up to see every warm intro you have to Fimmcyte

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Fimmcyte team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

FimmCyte develops targeted immunotherapies for fibro-inflammatory diseases, with a focus on conditions like endometriosis affecting women. The company aims to create disease-modifying treatments for chronic diseases impacting women's health.

Founders & leadership

MSMohaned Shilaih
Mohaned ShilaihPhD, CEO
VVValentina Vongrad
Valentina VongradPhD, CSOValentina Vongrad is Chief Scientific Officer at FimmCyte, which develops targeted immunotherapies for fibro-inflammatory diseases. Her research background spans gene therapy, oncology, immunotherapy, vaccines, molecular virology, and immunology.
MCMaureen Cronin
Maureen CroninMD-PhD, CMOMaureen Cronin is an MD-PhD who serves as Chief Medical Officer at FimmCyte, a company developing targeted immunotherapies for fibro-inflammatory diseases. She has worked in pharmaceutical medical affairs, product development, and lifecycle management.

Board

MK
Markus KalousekPhD, Chair

Investors · 1

Frequently asked questions

What does Fimmcyte do?
FimmCyte develops targeted immunotherapies for fibro-inflammatory diseases, with a focus on conditions like endometriosis affecting women. The company aims to create disease-modifying treatments for chronic diseases impacting women's health.
Who are Fimmcyte's investors?
Fimmcyte's investors include Kickfund.
Where is Fimmcyte headquartered?
Fimmcyte is headquartered in Basel, CH.